Share
     
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
14:30
TUAC0201
Continuing low HIV incidence in the expanded pre-exposure prophylaxis (PrEP) implementation in communities - New South Wales study (EPIC-NSW)
Andrew Grulich, University of New South Wales - Kirby Institute, Australia
Abstract
14:45
TUAC0202
Incidence of HIV-infection with daily or on-demand PrEP with TDF/FTC in Paris area. Update from the ANRS Prevenir Study
Jean-Michel Molina, St-Louis Hospital and University, France
Abstract
Slides
15:00
TUAC0203
High adherence and sustained impact on HIV-1 incidence: Final results of an open-label extension trial of the dapivirine vaginal ring
Jared Baeten, University of Washington, Seattle, United States
Abstract
Slides
15:15
TUAC0204
What is the effect of layered prevention interventions on HIV risk among adolescent girls in Zambia?
Sanyukta Mathur, Population Council, United States
Abstract
15:30
TUAC0205LB
Sitakhela Likusasa Impact Evaluation: results of a cluster randomized control trial (cRCT) of financial incentives for HIV prevention among adolescent girls and young women (AGYW) in Eswatini
Khanyakwezwe Mabuza, National Emergency Response Council on HIV and AIDS (NERCHA), Swaziland
Abstract
Slides